37 Autophagy is a physiological process that involves the engulfment and degradation of organelles. Choi and colleagues demonstrate that autophagy is important for the removal of damaged mitochondria and thus the control of inflammation. Nakahira K. (2011). Nature Immunology 12:222–230.
http://www.nature.com/ni/journal/v12/n3/abs/ni.1980.html
36 LAT ubiquitylation as a molecular checkpoint for attenuation of T-cell signaling.
Balagopalan L et al. (2011). PNAS 108:2885-2890.
http://www.pnas.org/content/108/7/2885.abstract
35 Signaling mechanisms in the restoration of impaired immune function due to diet-induced obesity. Zhou Q et al. (2011). PNAS 108:2867-2872.
http://www.pnas.org/content/108/7/2867.abstract
34 PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice. Okazaki T et al. (2011).JEM 208:395-407.
http://jem.rupress.org/content/208/2/395.abstract
33 TH17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Moffitt KL et al. (2011) Cell Host and Microbe 9:158-165.
http://www.cell.com/cell-host-microbe/abstract/S1931-3128(11)00028-X
32 IL-7 engages multiple echanisms to overcome chronic viral infection and limit organ pathology. Pellegrini M, et al. (2011). Cell 144: 601-613.
http://www.cell.com/abstract/S0092-8674(11)00012-2
31 Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3′ to 5′ exonuclease activity essential for immune suppression. Hastie KM, et al. (2011). PNAS 108:2396-2401.
http://www.pnas.org/content/108/6/2396.abstract
30 CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. Vacca P. et al. (2011). PNAS 108:2402-2407.
http://www.pnas.org/content/108/6/2402.abstract
29 Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Calderon B, et al. (2011). PNAS 108:1561-1566.
http://www.pnas.org/content/108/4/1561.abstract
28 Expression of miR-124, a microglial microRNA, reduces disease in a mouse model of multiple sclerosis by inhibiting the transcription factor C/EBP-α and its downstream target PU.1.
Ponomarev ED, et al. (2011). Nature Medicine 17:64–70.
http://www.nature.com/nm/journal/v17/n1/abs/nm.2266.html
|
